Compared to other lymphoproliferative disorders, clinical manifestations are highly heterogeneous in WM as they are not only related to marrow disease burden, but also to symptoms that are mediated by the monoclonal IgM. Here, CD40LG is linked to lymphoproliferative syndrome.